PMC:7558914 / 375-803
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 43 | 247-265 | Chemical | denotes | Hydroxychloroquine | MESH:D006886 |
| 44 | 404-422 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 66 | 339-358 | Disease | denotes | respiratory illness | MESH:D012140 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 339-358 | Phenotype | denotes | respiratory illness | http://purl.obolibrary.org/obo/HP_0002086 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 183-246 | Sentence | denotes | All protocols included were the latest updates as of July 2020. |
| T7 | 247-394 | Sentence | denotes | Hydroxychloroquine in monotherapy was the most frequent antiviral drug recommended for mild respiratory illness with clinical risk factors (33.3%). |